Inmazeb 61755-0019
Generic: Atoltivimab, Maftivimab, And Odesivimab-Ebgn
Product NDC
61755-0019- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 29, 2021
- Listing Expires
- December 31, 2026
- Application
- BLA761169
Need to source Inmazeb? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atoltivimab | 483.3 mg/14.5mL |
| Maftivimab | 483.3 mg/14.5mL |
| Odesivimab | 483.3 mg/14.5mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00)